169 related articles for article (PubMed ID: 21099384)
21. IgG4 Disease: Is It or Isn't It?
Jones ST; Ali MH; Lin AY; Moss HE; Srinivasan A; MacIntosh PW
J Neuroophthalmol; 2017 Mar; 37(1):70-74. PubMed ID: 27636750
[No Abstract] [Full Text] [Related]
22. Hypercalcemia in Necrobiotic Xanthogranuloma: First Reported Case and Insight Into Treatment.
Sfeir JG; Zogala RJ; Popii VB
J Bone Miner Res; 2017 Apr; 32(4):784-787. PubMed ID: 27886405
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of necrobiotic xanthogranuloma with total glucosides of paeony.
Li S; Chen AJ; Fang S; Li H
Dermatol Ther; 2014; 27(5):304-6. PubMed ID: 24774012
[TBL] [Abstract][Full Text] [Related]
24. Visual Dermatology: Necrobiotic Xanthogranuloma.
González-López MA; González-Vela MC
J Cutan Med Surg; 2021; 25(6):644. PubMed ID: 32726147
[No Abstract] [Full Text] [Related]
25. Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia.
Lan X; Yang X; Jiang Y
J Dermatol; 2023 Sep; 50(9):e299-e300. PubMed ID: 37082805
[No Abstract] [Full Text] [Related]
26. Necrobiotic xanthogranuloma and polymyositis in a patient with squamous cell lung cancer: a new paraneoplastic entity?
Ramic L; Steiner A; Breier F; Kutzner H; Sator P; Feldmann R
Eur J Dermatol; 2020 Dec; 30(6):746-747. PubMed ID: 33237031
[No Abstract] [Full Text] [Related]
27. Extrafacial necrobiotic xanthogranuloma and a disseminated marginal zone B lymphoma: a unique tissue collision.
Fourmond S; Pham-Ledard A; Vergier B; Peyrot I; Beylot-Barry M; Ducharme O
Int J Dermatol; 2024 Jan; 63(1):113-114. PubMed ID: 37830310
[No Abstract] [Full Text] [Related]
28. A rare case of disseminated skin and mucosal necrobiotic xanthogranuloma and xanthoma.
AlGain M; Szalat R; Vignon-Pennamen MD; Malphettes M; Vignon M; de Masson A; Bagot M; Rybojad M; Asli B; Arnulf B; Bouaziz JD
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e3-e5. PubMed ID: 26810089
[No Abstract] [Full Text] [Related]
29. Case Report: Corneal perforation secondary to orbital cellulitis caused by
Dong Y; Tian M
Eur J Ophthalmol; 2023 May; 33(3):NP66-NP69. PubMed ID: 35377259
[TBL] [Abstract][Full Text] [Related]
30. Vulvar necrobiotic xanthogranuloma.
DeLuca IJ; Grossman ME
J Am Acad Dermatol; 2014 Dec; 71(6):e247-8. PubMed ID: 25454046
[No Abstract] [Full Text] [Related]
31. Necrobiotic xanthogranuloma: a 30-year single-center experience.
Hilal T; DiCaudo DJ; Connolly SM; Reeder CB
Ann Hematol; 2018 Aug; 97(8):1471-1479. PubMed ID: 29568990
[TBL] [Abstract][Full Text] [Related]
32. Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
[TBL] [Abstract][Full Text] [Related]
33. A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.
Nelson CA; Zhong CS; Hashemi DA; Ashchyan HJ; Brown-Joel Z; Noe MH; Imadojemu S; Micheletti RG; Vleugels RA; Wanat KA; Rosenbach M; Mostaghimi A
JAMA Dermatol; 2020 Mar; 156(3):270-279. PubMed ID: 31940000
[TBL] [Abstract][Full Text] [Related]
34. Treatment of necrobiotic xanthogranuloma - a systematic review.
Miguel D; Lukacs J; Illing T; Elsner P
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
[TBL] [Abstract][Full Text] [Related]
35. Stupendous skin nodules: Necrobiotic xanthogranuloma with IgA-λ and IgG-κ monoclonal gammopathy.
Liu Z; Cao X; Wan C
J Dermatol; 2023 Feb; 50(2):e89-e91. PubMed ID: 36317505
[No Abstract] [Full Text] [Related]
36. [Diffuse plane normolipemic xanthomatosis and necrobiotic xanthogranuloma associated with monoclonal gammopathy--determining the disease stage with PET-CT and treatment experience. Two case studies and literature review].
Adam Z; Zahradová L; Krejcí M; Pour L; Koukalová R; Rehák Z; Feit J; Kren L; Mechl M; Vasků V; Sirotková A; Hájek R; Mayer J
Vnitr Lek; 2010 Nov; 56(11):1158-68. PubMed ID: 21250495
[TBL] [Abstract][Full Text] [Related]
37. Ophthalmological considerations in necrobiotic xanthogranuloma.
Ali FR; Young HS
Clin Exp Dermatol; 2016 Jul; 41(5):563-4. PubMed ID: 26936405
[No Abstract] [Full Text] [Related]
38. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
Higgins LS; Go RS; Dingli D; Kumar SK; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lust JA; Kapoor P; Leung N; Lin Y; Kourelis TV; Gertz MA; Kyle RA; Gonsalves WI
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):447-52. PubMed ID: 27238425
[TBL] [Abstract][Full Text] [Related]
39. Adult Orbital Xanthogranulomatous Disease: A Review with Emphasis on Etiology, Systemic Associations, Diagnostic Tools, and Treatment.
Kerstetter J; Wang J
Dermatol Clin; 2015 Jul; 33(3):457-63. PubMed ID: 26143425
[TBL] [Abstract][Full Text] [Related]
40. Image Gallery: Necrobiotic xanthogranuloma in association with chronic myelomonocytic leukaemia.
Edwards LR; Kidd LL; Gru AA; Wilson BB
Br J Dermatol; 2017 Feb; 176(2):e16. PubMed ID: 28244100
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
